Memorial Sloan-Kettering Cancer Center;St. Jude Children's Research Hospital
发明人:
Scott William LOWE,Charles J. SHERR,Chun-Hao HUANG,Amaia LUJAMBIO
申请号：
US16544180
公开号：
US20200054640A1
申请日:
2019.08.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method of determining sensitivity to cancer treatment includes the step of determining the presence of overexpression of MYC in a biological sample from a patient suffering from cancer, wherein the presence of overexpression of MYC indicates a sensitivity to a treatment by a CDK9 inhibitor and wherein the cancer is selected from the group consisting of carcinoma, leukemia, and lymphoma.
